Clinical trials
Phase 4 Shoulder Pain trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital for Special Surgery, New York | 2 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| Brooke Army Medical Center | 1 |
| Campbell Clinic | 1 |
| Cedars-Sinai Medical Center | 1 |
| HealthPartners Institute | 1 |
| Henry Ford Health System | 1 |
| Hospital for Special Surgery Florida | 1 |
| Maimonides Medical Center | 1 |
| Milton S. Hershey Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shoulder Pain | 20 |
| Postoperative Pain | 4 |
| Rotator Cuff Injuries | 4 |
| Agnosia | 2 |
| Hernia | 1 |
| Hernia, Hiatal | 1 |
| Osteoarthritis | 1 |
| Referred Pain | 1 |
| Shoulder Injuries | 1 |
| Tendinopathy | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.